Filed: 11/13/2024ACC: 0001104659-24-116967
📋 What this filing means
ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC filed this quarterly 13F‑HR report disclosing 14 equity positions with a total reported market value of $1.08B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
14
Positions
$1.08B
Total AUM (reported)
57.79M
Total Shares
Allocation by class
COMMON STOCK$1.08B100.0%
Portfolio Concentration
Top 3$667.63M61.9%
4–10$396.00M36.7%
11–25$15.09M1.4%
Top 3 weight
61.9%
Top 10 weight
98.6%
Voting Authority Distribution
Total shares with voting rights: 57.79M
Sole
Full voting authority
57.79M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole14
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings14
Rows:
Dyne Therapeutics, Inc.
SOLEShares8.02M
TypeSH
Market value$288.08M
26.71%
Sole
8.02M
Shared
0.00
None
0.00
Kymera Therapeutics, Inc.
SOLEShares4.90M
TypeSH
Market value$231.75M
21.48%
Sole
4.90M
Shared
0.00
None
0.00
Third Harmonic Bio, Inc.
SOLEShares10.91M
TypeSH
Market value$147.80M
13.70%
Sole
10.91M
Shared
0.00
None
0.00
Disc Medicine, Inc.
SOLEShares2.51M
TypeSH
Market value$123.31M
11.43%
Sole
2.51M
Shared
0.00
None
0.00
Q32 Bio, Inc.
SOLEShares2.09M
TypeSH
Market value$93.35M
8.65%
Sole
2.09M
Shared
0.00
None
0.00
Day One Biopharmaceuticals, Inc.
SOLEShares6.43M
TypeSH
Market value$89.57M
8.30%
Sole
6.43M
Shared
0.00
None
0.00
Korro Bio, Inc.
SOLEShares1.14M
TypeSH
Market value$38.00M
3.52%
Sole
1.14M
Shared
0.00
None
0.00
Generation Bio, Co.
SOLEShares8.28M
TypeSH
Market value$20.45M
1.90%
Sole
8.28M
Shared
0.00
None
0.00
Vigil Neuroscience, Inc.
SOLEShares5.84M
TypeSH
Market value$19.85M
1.84%
Sole
5.84M
Shared
0.00
None
0.00
Tectonic Therapeutics, Inc.
SOLEShares378.45K
TypeSH
Market value$11.47M
1.06%
Sole
378.45K
Shared
0.00
None
0.00
Ikena Oncology, Inc.
SOLEShares5.02M
TypeSH
Market value$8.68M
0.80%
Sole
5.02M
Shared
0.00
None
0.00
Aerovate Therapeutics, Inc.
SOLEShares1.80M
TypeSH
Market value$3.76M
0.35%
Sole
1.80M
Shared
0.00
None
0.00
Dianthus Therapeutics, Inc.
SOLEShares76.98K
TypeSH
Market value$2.11M
0.20%
Sole
76.98K
Shared
0.00
None
0.00
Spero Therapeutics, Inc.
SOLEShares402.88K
TypeSH
Market value$539.9K
0.05%
Sole
402.88K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Dyne Therapeutics, Inc.SOLE | Common Stock | 8.02M | SH | $288.08M 26.71% | 8.02M | 0.00 | 0.00 |
Kymera Therapeutics, Inc.SOLE | Common Stock | 4.90M | SH | $231.75M 21.48% | 4.90M | 0.00 | 0.00 |
Third Harmonic Bio, Inc.SOLE | Common Stock | 10.91M | SH | $147.80M 13.70% | 10.91M | 0.00 | 0.00 |
Disc Medicine, Inc.SOLE | Common Stock | 2.51M | SH | $123.31M 11.43% | 2.51M | 0.00 | 0.00 |
Q32 Bio, Inc.SOLE | Common Stock | 2.09M | SH | $93.35M 8.65% | 2.09M | 0.00 | 0.00 |
Day One Biopharmaceuticals, Inc.SOLE | Common Stock | 6.43M | SH | $89.57M 8.30% | 6.43M | 0.00 | 0.00 |
Korro Bio, Inc.SOLE | Common Stock | 1.14M | SH | $38.00M 3.52% | 1.14M | 0.00 | 0.00 |
Generation Bio, Co.SOLE | Common Stock | 8.28M | SH | $20.45M 1.90% | 8.28M | 0.00 | 0.00 |
Vigil Neuroscience, Inc.SOLE | Common Stock | 5.84M | SH | $19.85M 1.84% | 5.84M | 0.00 | 0.00 |
Tectonic Therapeutics, Inc.SOLE | Common Stock | 378.45K | SH | $11.47M 1.06% | 378.45K | 0.00 | 0.00 |
Ikena Oncology, Inc.SOLE | Common Stock | 5.02M | SH | $8.68M 0.80% | 5.02M | 0.00 | 0.00 |
Aerovate Therapeutics, Inc.SOLE | Common Stock | 1.80M | SH | $3.76M 0.35% | 1.80M | 0.00 | 0.00 |
Dianthus Therapeutics, Inc.SOLE | Common Stock | 76.98K | SH | $2.11M 0.20% | 76.98K | 0.00 | 0.00 |
Spero Therapeutics, Inc.SOLE | Common Stock | 402.88K | SH | $539.9K 0.05% | 402.88K | 0.00 | 0.00 |